Journal: Frontiers in Immunology
Article Title: NF-κB/IL-6 axis drives impaired corneal wound healing in aqueous-deficient dry eye
doi: 10.3389/fimmu.2025.1684290
Figure Lengend Snippet: Effects of NF-κB or IL-6 inhibition on corneal re‐epithelialization and nerve regeneration in LGE-treated mice. (A) Representative fluorescein sodium staining images of corneal epithelial wounds at multiple time points (0–42 hours) after abrasion in control mice, and LGE‐treated mice administered PBS, CAPE, isotype IgG, or anti‐IL‐6 antibody. (B, C) Quantification of residual corneal wound area over time in each group of mice. (B) Comparison among control, LGE + PBS, and LGE + CAPE groups. (C) Comparison among control, LGE + isotype IgG, and LGE + anti‐IL‐6 antibody groups. (D, E) Quantification of dividing basal epithelial cells in each group of mice. (D) Comparison among control, LGE + PBS, and LGE + CAPE groups; (E) Comparison among control, LGE + isotype IgG, and LGE + anti‐IL‐6 antibody groups. (F) Immunofluorescence images of whole-mount corneal nerves at 6 days post‐injury using anti‐β‐III tubulin antibody conjugated with NL557. Upper panels show full corneal view (scale bars = 500 μm); lower panels show magnified central region (scale bars = 200 μm). (G, H) Quantification of corneal nerve fiber density (G) and mechanical sensitivity (H) in control, LGE + PBS, and LGE + CAPE groups. (I, J) Quantification of corneal nerve fiber density (I) and mechanical sensitivity (J) in control, LGE + isotype IgG, and LGE + anti‐IL‐6 antibody groups. All values are presented as mean ± SD. Sample size: n = 6 mice in each group (B–E, G–J) . Statistical significance: * P < 0.05, ** P < 0.01, and *** P < 0.001 for LGE‐treated mice versus control mice; # P < 0.05, ## P < 0.01, and ### P < 0.001 for LGE + CAPE or anti‐IL‐6 antibody versus respective vehicle (PBS or IgG); + P < 0.05, ++ P < 0.01, and +++ P < 0.001 for LGE + CAPE or anti‐IL‐6 antibody versus control.
Article Snippet: Subsequently, whole corneas were systematically incubated overnight at 4°C with one of the following standardized primary antibodies: i) Anti‐mouse Ly6G conjugated with fluorescein isothiocyanate (FITC; 1:100 dilution; BD Biosciences, Cat. No. 551460); ii) Anti‐mouse GL3 conjugated with phycoerythrin (PE; 1:100 dilution; BD Biosciences, Cat. No. 553178); iii) Anti‐β‐III tubulin conjugated with NL557 (1:10 dilution; R&D Systems, Cat. No. NL1195R).
Techniques: Inhibition, Staining, Control, Comparison, Immunofluorescence